Obesity, inflammation, and macrophages

Nestle Nutrition Workshop Series: Pediatric Program

Volumn 63, Issue , 2009, Pages 151-162

  Subramanian, Vidya ^a   Ferrante Jr , Anthony W ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RODENTIA;

CYTOKINE;

ADIPOSE TISSUE; ARTICLE; HEALTH; HUMAN; INFLAMMATION; MACROPHAGE; MONOCYTE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE;

ADIPOSE TISSUE; CYTOKINES; HUMANS; INFLAMMATION; MACROPHAGES; MONOCYTES; OBESITY; PREVALENCE; WORLD HEALTH;

EID: 66149098965     PISSN: 16616677     EISSN: 16623878     Source Type: Book Series    
DOI: 10.1159/000209979     Document Type: Article

References (30)

1. World Health Organization: The World Health Report 2002 - Reducing Risks, Promoting Healthy Life. Geneva, World Health Organization, 2002.
2. World Health Organization: Obesity and Overweight; in Fact Sheet No. 311. Geneva, World Health Organization, 2006.
3. Bibbins-Domingo K, Coxson P, Pletcher MJ, et al: Adolescent overweight and future adult coronary heart disease. N Engl J Med 2007;357:2371-2379.
4. Wellen KE, Hotamisligil GS: Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111- 1119.
5. Janeway CA, Walport M, Shlomchik M: Immunobiology, ed 6. New York, Garland, 2004.
6. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
7. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994;43:1271-1278.
8. Ofei F, Hurel S, Newkirk J, et al: Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996;45:881-885.
9. Paquot N, Castillo MJ, Lefèbvre PJ, Scheen AJ: No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients. J Clin Endocrinol Metab 2000;85:1316-1319.
10. Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M: Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 2003;300:674-678.
11. Fain JN, Madan AK, Hiler ML, et al: Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-2282.
12. Weisberg S, McCann D, Desai M, et al: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808.
13. Xu H, Barnes GT, Yang Q, et al: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830.
14. Cancello R, Tordjman J, Poitou C, et al: Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006;55:1554-1561.
15. Charo IF, Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006;354:610-621.
16. Dong ZM, Gutierrez-Ramos JC, Coxon A, et al: A new class of obesity genes encodes leukocyte adhesion receptors. Proc Natl Acad Sci USA 1997;94:7526-7530.
17. Gregoire FM, Zhang Q, Smith SJ, et al: Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice. Am J Physiol Endocrinol Metab 2002;282:E703-E713.
18. Kamei N, Tobe K, Suzuki R, et al: Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 2006;281:26602-26614.
19. Kanda H, Tateya S, Tamori Y, et al: MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006;116:1494-1505.
20. Inouye KE, Shi H, Howard JK, et al: Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 2007;56:2242-2250.
21. Weisberg SP, Hunter D, Huber R, et al: CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006;116:115-124.
22. Cecchini MG, Dominguez MG, Mocci S, et al: Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 1994;120:1357-1372.
23. Dai XM, Ryan GR, Hapel AJ, et al: Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002;99:111-120.
24. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.
25. Hevener AL, Olefsky JM, Reichart D, et al: Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinedio-nes. J Clin Invest 2007;117:1658-1669.
26. Odegaard JI, et al: Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007;447(7148):1116-1120.
27. Cancello R, Henegar C, Viguerie N, et al: Reduction of macrophage infiltration and chemoat-tractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005;54:2277-2286.
28. Ricote M, Li AC, Willson TM, et al: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391:79-82.
29. Di Gregorio GB, Yao-Borengasser A, Rasouli N, et al: Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cyto-kine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005;54:2305- 2313.
30. Mohanty P, Aljada A, Ghanim H, et al: Evidence for a potent antiinflammatory effect of rosigli-tazone. J Clin Endocrinol Metab 2004;89:2728-2735.